Submission for OMB Review; Emergency Clearance Request Human Influenza Surveillance of Health Care Centers in the United States and Taiwan, 10494-10495 [2015-04069]

Download as PDF 10494 Federal Register / Vol. 80, No. 38 / Thursday, February 26, 2015 / Notices Monday through Friday, and will be posted to the docket at https:// www.regulations.gov. Transcripts: As soon as a transcript is available, FDA will post it at https:// wwww.fda.gov/NewsEvents/ MeetingsConferencesWorkshops/ ucm433552.htm. Dated: February 20, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–03974 Filed 2–25–15; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration rmajette on DSK2VPTVN1PROD with NOTICES Advisory Committee on Organ Transplantation; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Committee on Organ Transplantation (ACOT). Date and Time: March 12, from 8:30 a.m. to 4:30 p.m. Eastern Standard Time. March 13, from 8:30 a.m. to 12:30 p.m. Eastern Standard Time. Place: Health Resources and Services Administration, 5600 Fishers Lane, Room 05W11, Rockville, MD 20857. Status: The meeting will be open to the public. Purpose: Under the authority of 42 U.S.C. Section 217a, Section 222 of the Public Health Service Act, as amended, and 42 CFR 121.12 (2000), ACOT was established to assist the Secretary in enhancing organ donation, ensuring that the system of organ transplantation is grounded in the best available medical science, and assuring the public that the system is as effective and equitable as possible, thereby increasing public confidence in the integrity and effectiveness of the transplantation system. ACOT is composed of up to 25 members including the Chair. Members serve as Special Government Employees and have diverse backgrounds in fields such as organ donation, health care public policy, transplantation medicine and surgery, critical care medicine, and other medical specialties involved in the identification and referral of donors, non-physician transplant professions, nursing, epidemiology, immunology, law and bioethics, behavioral sciences, economics and statistics, as well as representatives of transplant candidates, transplant recipients, organ donors, and family members. VerDate Sep<11>2014 15:27 Feb 25, 2015 Jkt 235001 Agenda: The Committee will hear presentations, including those on the following topics: Kidney Paired Donation; Vascularized Composite Allografts; Donor Management Research; Living Donation; and the Affordable Care Act and Transplantation. Agenda items are subject to change as priorities indicate. After Committee discussions, members of the public will have an opportunity to comment. Because of the Committee’s full agenda and timeframe in which to cover the agenda topics, public comment will be limited. All public comments will be included in the record of the ACOT meeting. Meeting summary notes will be posted on the Department’s organ donation Web site at https://www.organdonor.gov/ legislation/advisory.html#meetings. The draft meeting agenda will be posted on www.blsmeetings.net/ACOT. Those participating on this meeting should pre-register by visiting www.blsmeetings.net/ACOT. The deadline to pre-register for this meeting is Wednesday, March 11, 2015. Registration will be confirmed on site. For all logistical questions and concerns, please contact Anita Allen, Seamon Corporation at 301–658–3442 or send an email to aallen@ seamoncorporation.com. Public Comment: It is preferred that persons interested in providing an oral presentation email a written request, along with a copy of their presentation, to Patricia Stroup, MBA, MPA, Executive Secretary, Healthcare Systems Bureau, Health Resources and Services Administration, at pstroup@hrsa.gov. Requests should contain the name, address, telephone number, email address, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may request it during the public comment period. Public participation and ability to comment will be limited to time as it permits. FOR FURTHER INFORMATION CONTACT: Patricia Stroup, MBA, MPA, Executive Secretary, Healthcare Systems Bureau, Health Resources and Services Administration, 5600 Fishers Lane, PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 Room 17W65, Rockville, MD 20857; telephone (301) 443–1127. Jackie Painter, Director, Division of the Executive Secretariat. [FR Doc. 2015–03929 Filed 2–25–15; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; Emergency Clearance Request Human Influenza Surveillance of Health Care Centers in the United States and Taiwan In accordance with Section 3507(j) of the Paperwork Reduction Act of 1995, the National Institute of Allergy and Infectious Diseases (NIAID), the National Institutes of Health (NIH), has submitted to the Office of Management and Budget (OMB) a request for emergency review and processing of this information collection by March 7, 2015. NIAID is requesting emergency processing of this information collection, pursuant to 5 CFR 1320.13, because NIAID cannot reasonably comply with the normal clearance procedures which would cause a delay and likely prevent or substantially disrupt the collection of information. A delay in starting the information collection would hinder the agency in accomplishing its mission to the detriment of the public good. Public harm could result through the loss of critically needed information to understand the causes of severity of influenza and associated morbidity and mortality during the Northern hemisphere 2014–15 influenza season. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the SUMMARY: E:\FR\FM\26FEN1.SGM 26FEN1 Federal Register / Vol. 80, No. 38 / Thursday, February 26, 2015 / Notices burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@ omb.eop.gov or by fax to 202–395–6974, Attention: NIH Desk Officer. DATES: Comment due date: Comments regarding this information collection are best assured of having their full effect if received within 7 days of the date of this publication. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the data collection plans and 10495 disease—a critical knowledge gap impacting effectiveness of decisionmaking around patient care. The 2014– 15 influenza season is unique because the dominant circulating strain is an H3N2 strain that is not sensitive to the immunity induced by the influenza vaccine formulation administered to the general public. Our study will provide insight into viral determinants that may be contributing to the severity of influenza and associated morbidity and mortality this season. Capturing samples from this influenza season is essential for understanding the public health implications the virus may have in the future, and discerning the reasons behind the severity of the disease it causes. OMB approval is requested for 6 months. There are no costs to respondents other than their time. The total estimated annualized burden hours are 500. instruments, contact Dr. Diane Post, Program Officer, Respiratory Diseases Branch, NIAID, NIH 5601 Fishers Lane, Bethesda, MD or call non-toll-free number at 240–627–3348 or email your request, including your address to: postd@niaid.nih.gov SUPPLEMENTARY INFORMATION: Proposed Collection: Human Influenza Surveillance of Health Care Centers in the United States and Taiwan, (NIAID), 0925—NEW, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). Need and Use of Information Collection: This study will identify individuals with influenza through focused surveillance in key regions of the United States and Taiwan, rapidly identify circulating influenza strains to identify those with pandemic potential and create an invaluable bank of human samples from patients with influenza to characterize the basis of severe ESTIMATED ANNUALIZED BURDEN HOURS Type of respondent Number of respondents Number of responses per respondent Average burden per response (in hours) Total burden hours Patients ............................................................................................................ 500 2 30/60 500 Dated: February 20, 2015. Dione Washington, Project Clearance Liaison, NIAID, NIH, NIAID, NIH. [FR Doc. 2015–04069 Filed 2–25–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health rmajette on DSK2VPTVN1PROD with NOTICES Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Sep<11>2014 15:27 Feb 25, 2015 Jkt 235001 Name of Committee: Center for Scientific Review Special Emphasis Panel, Fellowships: Risk, Prevention, and Health Behavior Overflow. Date: March 18, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Lee S. Mann, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3224, MSC 7808, Bethesda, MD 20892, 301–435– 0677, mannl@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Innate/ Adaptive Immunology and Vaccine Development. Date: March 19–20, 2015. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Patrick K. Lai, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2215, MSC 7812, Bethesda, MD 20892, 301–435– 1052, laip@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Fellowships: Risk, Prevention and Health Behavior. PO 00000 Frm 00041 Fmt 4703 Sfmt 9990 Date: March 23–24, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Martha M. Faraday, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3110, MSC 7808, Bethesda, MD 20892, (301) 435– 3575, faradaym@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 20, 2015. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2015–03936 Filed 2–25–15; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\26FEN1.SGM 26FEN1

Agencies

[Federal Register Volume 80, Number 38 (Thursday, February 26, 2015)]
[Notices]
[Pages 10494-10495]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-04069]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; Emergency Clearance Request Human 
Influenza Surveillance of Health Care Centers in the United States and 
Taiwan

SUMMARY: In accordance with Section 3507(j) of the Paperwork Reduction 
Act of 1995, the National Institute of Allergy and Infectious Diseases 
(NIAID), the National Institutes of Health (NIH), has submitted to the 
Office of Management and Budget (OMB) a request for emergency review 
and processing of this information collection by March 7, 2015. NIAID 
is requesting emergency processing of this information collection, 
pursuant to 5 CFR 1320.13, because NIAID cannot reasonably comply with 
the normal clearance procedures which would cause a delay and likely 
prevent or substantially disrupt the collection of information. A delay 
in starting the information collection would hinder the agency in 
accomplishing its mission to the detriment of the public good. Public 
harm could result through the loss of critically needed information to 
understand the causes of severity of influenza and associated morbidity 
and mortality during the Northern hemisphere 2014-15 influenza season. 
The National Institutes of Health may not conduct or sponsor, and the 
respondent is not required to respond to, an information collection 
that has been extended, revised, or implemented on or after October 1, 
1995, unless it displays a currently valid OMB control number. Written 
comments and/or suggestions from the public and affected agencies are 
invited on one or more of the following points: (1) Whether the 
proposed collection of information is necessary for the proper 
performance of the function of the agency, including whether the 
information will have practical utility; (2) The accuracy of the 
agency's estimate of the burden of the proposed collection of 
information, including the validity of the methodology and assumptions 
used; (3) Ways to enhance the quality, utility, and clarity of the 
information to be collected; and (4) Ways to minimize the

[[Page 10495]]

burden of the collection of information on those who are to respond, 
including the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974, 
Attention: NIH Desk Officer.

DATES: Comment due date: Comments regarding this information collection 
are best assured of having their full effect if received within 7 days 
of the date of this publication.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the data collection plans and 
instruments, contact Dr. Diane Post, Program Officer, Respiratory 
Diseases Branch, NIAID, NIH 5601 Fishers Lane, Bethesda, MD or call 
non-toll-free number at 240-627-3348 or email your request, including 
your address to: postd@niaid.nih.gov

SUPPLEMENTARY INFORMATION: 
    Proposed Collection: Human Influenza Surveillance of Health Care 
Centers in the United States and Taiwan, (NIAID), 0925--NEW, National 
Institute of Allergy and Infectious Diseases (NIAID), National 
Institutes of Health (NIH).
    Need and Use of Information Collection: This study will identify 
individuals with influenza through focused surveillance in key regions 
of the United States and Taiwan, rapidly identify circulating influenza 
strains to identify those with pandemic potential and create an 
invaluable bank of human samples from patients with influenza to 
characterize the basis of severe disease--a critical knowledge gap 
impacting effectiveness of decision-making around patient care. The 
2014-15 influenza season is unique because the dominant circulating 
strain is an H3N2 strain that is not sensitive to the immunity induced 
by the influenza vaccine formulation administered to the general 
public. Our study will provide insight into viral determinants that may 
be contributing to the severity of influenza and associated morbidity 
and mortality this season. Capturing samples from this influenza season 
is essential for understanding the public health implications the virus 
may have in the future, and discerning the reasons behind the severity 
of the disease it causes.
    OMB approval is requested for 6 months. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 500.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                  Number of      Average burden
             Type of respondent                  Number of      responses per     per response     Total burden
                                                respondents       respondent       (in hours)         hours
----------------------------------------------------------------------------------------------------------------
Patients....................................             500                2            30/60              500
----------------------------------------------------------------------------------------------------------------


    Dated: February 20, 2015.
Dione Washington,
Project Clearance Liaison, NIAID, NIH, NIAID, NIH.
[FR Doc. 2015-04069 Filed 2-25-15; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.